Survival in patients with severe ischemic cardiomyopathy undergoing revascularization versus medical therapy: association with end-systolic volume and viability.

MLA

Kwon DH, et al. “Survival in Patients with Severe Ischemic Cardiomyopathy Undergoing Revascularization versus Medical Therapy: Association with End-Systolic Volume and Viability.” Circulation, vol. 126, no. S1, Sept. 2012, pp. S3-8. EBSCOhost, https://doi.org/10.1161/circulationaha.111.084434.

APA

Kwon DH, Hachamovitch R, Popovic ZB, Starling RC, Desai MY, Flamm SD, Lytle BW, & Marwick TH. (2012). Survival in patients with severe ischemic cardiomyopathy undergoing revascularization versus medical therapy: association with end-systolic volume and viability. Circulation, 126(S1), S3-8. https://doi.org/10.1161/circulationaha.111.084434

Chicago

Kwon DH, Hachamovitch R, Popovic ZB, Starling RC, Desai MY, Flamm SD, Lytle BW, and Marwick TH. 2012. “Survival in Patients with Severe Ischemic Cardiomyopathy Undergoing Revascularization versus Medical Therapy: Association with End-Systolic Volume and Viability.” Circulation 126 (S1): S3-8. doi:10.1161/circulationaha.111.084434.